Literature DB >> 34241661

Quantitative dynamic contrast-enhanced MRI and readout segmentation of long variable echo-trains diffusion-weighted imaging in differentiating parotid gland tumors.

Nan Huang1, Zebin Xiao2, Yu Chen1, Dejun She1, Wei Guo1, Xiefeng Yang1, Qi Chen1, Dairong Cao1, Tanhui Chen3.   

Abstract

PURPOSE: To evaluate the ability of quantitative dynamic contrast-enhanced (DCE)-MRI and readout segmentation of long variable echo-trains diffusion-weighted imaging (RESOLVE-DWI) in differentiating parotid tumors (PTs) with different histological types.
METHODS: In this retrospective study, 123 patients with 145 histologically proven PTs who underwent both RESOLVE-DWI and DCE-MRI were enrolled including 51 pleomorphic adenomas (PAs), 52 Warthin's tumors (WTs), 27 other benign neoplasms (OBNs), and 15 malignant tumors (MTs). Quantitative parameters of DCE-MRI (Ktrans, Kep, and Ve) and the apparent diffusion coefficient (ADC) of lesions were calculated and analyzed. Kruskal-Wallis tests with Dunn-Bonferroni correction, logistic regression analyses, and receiver operating characteristic curve were used for statistical analyses.
RESULTS: PAs exhibited a lowest Ktrans among these four PTs. WTs demonstrated the highest Kep and lowest Ve values. WTs and MTs showed lower ADCmin values than PAs and OBNs. The combination of Kep and Ve provided 98.1% sensitivity, 85% specificity, and 98.7% accuracy for differentiating WTs from the other three PTs. The ADCmin cutoff value of ≤ 0.826 yielded 80.0% sensitivity, 92.3% specificity, and 90.3% accuracy for the differentiation of MTs from PAs and OBNs. Ktrans with a cutoff value of ≤ 0.185 achieved a sensitivity, specificity, and accuracy of 84.3, 70.4, and 79.5%, respectively, for discriminating PAs from OBNs.
CONCLUSION: The combination of quantitative DCE-MRI and RESOLVE-DWI is beneficial for characterizing four histological types of PTs.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  DCE-MRI; Diffusion; Magnetic resonance imaging; Parotid tumor; Perfusion; RESOLVE-DWI

Year:  2021        PMID: 34241661     DOI: 10.1007/s00234-021-02758-z

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  46 in total

Review 1.  Major salivary gland imaging.

Authors:  D M Yousem; M A Kraut; A A Chalian
Journal:  Radiology       Date:  2000-07       Impact factor: 11.105

2.  The significance of the margin in parotid surgery for pleomorphic adenoma.

Authors:  Robert L Witt
Journal:  Laryngoscope       Date:  2002-12       Impact factor: 3.325

3.  Parotidectomy: ten-year review of 237 cases at a single institution.

Authors:  David C Upton; Justin P McNamar; Nadine P Connor; Paul M Harari; Gregory K Hartig
Journal:  Otolaryngol Head Neck Surg       Date:  2007-05       Impact factor: 3.497

4.  Consensus statement by otolaryngologists on the diagnosis and management of benign parotid gland disease.

Authors:  P T Bradley; V Paleri; J J Homer
Journal:  Clin Otolaryngol       Date:  2012-08       Impact factor: 2.597

5.  Treatment of malignant neoplasms of the parotid gland.

Authors:  M Magnano; C F gervasio; L Cravero; G Machetta; W Lerda; G Beltramo; R Orecchia; R Ragona; M Bussi
Journal:  Otolaryngol Head Neck Surg       Date:  1999-11       Impact factor: 3.497

Review 6.  Staging and follow-up of high-grade malignant salivary gland tumours: The role of traditional versus functional imaging approaches - A review.

Authors:  Nicole Freling; Flavio Crippa; Roberto Maroldi
Journal:  Oral Oncol       Date:  2016-05-25       Impact factor: 5.337

7.  Myoepithelioma of salivary glands: report of 23 cases.

Authors:  J J Sciubba; R B Brannon
Journal:  Cancer       Date:  1982-02-01       Impact factor: 6.860

Review 8.  Pleomorphic adenoma of the parotid: formal parotidectomy or limited surgery?

Authors:  Peter Zbären; Vincent Vander Poorten; Robert L Witt; Julia A Woolgar; Ashok R Shaha; Asterios Triantafyllou; Robert P Takes; Alessandra Rinaldo; Alfio Ferlito
Journal:  Am J Surg       Date:  2012-10-11       Impact factor: 2.565

9.  Malignant parotid tumors: clinical use of MR imaging and histologic correlation.

Authors:  N J Freling; W M Molenaar; A Vermey; E L Mooyaart; A K Panders; A A Annyas; C J Thijn
Journal:  Radiology       Date:  1992-12       Impact factor: 11.105

10.  [Parotid gland masses: diagnostic value of MR imaging with histopathologic correlations].

Authors:  J-M Prades; A Oletski; M-B Faye; J-M Dumollard; A-P Timoshenko; C Veyret; M Peoc'h; C Martin
Journal:  Morphologie       Date:  2007-03
View more
  1 in total

Review 1.  Advanced magnetic resonance imaging findings in salivary gland tumors.

Authors:  Erkan Gökçe; Murat Beyhan
Journal:  World J Radiol       Date:  2022-08-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.